Recombinant Human TAT1 Protein，His & GST

TAT1, or Transporter Associated with Antigen Processing 1, is a protein that plays a crucial role in the immune response by facilitating the transport of peptides into the endoplasmic reticulum, where they are loaded onto MHC class I molecules for presentation to CD8+ T cells. The study of TAT1 has gained significant attention due to its implications in autoimmune diseases, cancer immunotherapy, and the understanding of peptide-MHC interactions. Researchers are particularly interested in its potential as a therapeutic target, as manipulating TAT1 expression or function could enhance the efficacy of vaccines and immunotherapies by improving antigen presentation. Moreover, TAT1 has been implicated in various cellular processes beyond antigen processing, including the regulation of cellular stress responses and apoptosis. The recombinant production of TAT1 has enabled detailed biochemical and biophysical characterization, allowing scientists to explore its structure-function relationships and develop inhibitors or modulators with potential clinical applications. Understanding the mechanisms that govern TAT1's activity could provide insights into immune evasion by tumors and other pathological conditions, paving the way for novel treatment strategies that harness the body's immune system more effectively. Thus, the ongoing research into TAT1 recombinant proteins not only contributes to fundamental immunological knowledge but also has the potential to translate into significant advancements in therapeutic interventions.